Floatz logo

ROSIPTOR

Interstitial Cystitis

Aquinox Pharmaceuticals (Canada) Inc.Small moleculePhase 3Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

13 Active assets in the Interstitial Cystitis cohort.

Asset / SponsorPhaseRating
Cyclic Microgestin 1/20
Endeavor Health
Phase 4BB
Continuous Microgestin 1/20
Endeavor Health
Phase 4BB
Doxycycline
Insel Gruppe AG, University Hospital Bern
Phase 4B
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)-
Jocelyn Fitzgerald
Phase 3B
Amitriptyline
Jocelyn Fitzgerald
Phase 3B

View all 24 →

Same molecule, other indications

ROSIPTOR is also rated in:

Bladder Pain SyndromeDormant
CCC
Indicative ·
55 / 100
View asset →
chronic prostatitisDormant
CCC
Indicative ·
53 / 100
View asset →
Chronic Pelvic Pain SyndromeDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →